Press Release Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA Aug 24
Press Release Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Aug 13
Press Release Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13 Aug 10
Press Release Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel Jul 30
Press Release The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy Jul 29
Press Release Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel Jul 27